Financials
Value Q1, 25Q2, 25Q3, 25Q1, 26 TTM Selling/general/admin expenses 38.49 M45.73 M43.37 M46.31 M — Research & development ———— — Operating income 13.69 M27.77 M42.35 M10.25 M — Non-Operating Income, Total -18.11 M-15.16 M-3.7 M-2.63 M — Interest expense, net of interest capitalized 9.56 M11.24 M12.52 M9.75 M — Non-Operating Income, excl. Interest Expenses -18.11 M-14.01 M-2.66 M-2.72 M — Unusual income/expense 1.68 M-1.15 M-1.04 M98 K — Pretax income -4.42 M12.62 M18.16 M-17.57 M — Equity in earnings 261 K150 K1.39 M98 K — Taxes 1.19 M-2.9 M-3.68 M-3.18 M — Non-controlling/minority interest -123 K2.65 M3.31 M3.9 M — After tax other income/expense ———— — Net income before discontinued operations -5.48 M12.86 M18.53 M-18.28 M — Discontinued operations ———— — Net income -5.48 M12.86 M18.53 M-18.28 M — Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -5.51 M12.84 M18.5 M-18.33 M — Basic earnings per share (Basic EPS) -0.10.240.35-0.35 — Diluted earnings per share (Diluted EPS) -0.10.240.35-0.35 — Average basic shares outstanding 52.54 M52.64 M52.72 M52.89 M — Diluted shares outstanding 52.54 M52.82 M53.37 M52.89 M — EBITDA 56.03 M70.96 M46.26 M12.67 M — EBIT 32.09 M45.76 M19.02 M-16.59 M — Cost of revenue 300.91 M398.93 M441.66 M345 M — Other cost of goods sold ———— — Depreciation & amortization (cash flow) 23.94 M25.2 M27.23 M29.26 M —